Dr. Olivier Reynard is an expert virologist, he hold a doctorate from Ecole Pratique des Hautes Etudes University (La Sorbonne, Paris, France). He has over fiveteen years experience of virological research mainly in the field of academic research on hemorrhagic fever viruses but also as a consultant in major pharmaceutical industry and biotech companies. His expertise includes vaccine design and testing, virus isolation and manipulation in high containement facility (BSL4), cell and viral molecular biology, biochemistry study of proteins and design of antiviral drug screening assays. He is the author/co-author of several scientific peer reviewed articles and owned several patents. He act as an associate professor at Lyon Catholic University, where he teaches biosafety and virology in bachelor and M.Sc courses.

Highly pathogenic viruses, Ebola, CCHFV, drug screening, viral pathogenicity